tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Argenx Se (ARGX)
NASDAQ:ARGX
ARGX
Argenx Se
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding ARGX?
Track your performance easily
Link Broker

Argenx Se (ARGX) Stock News & Sentiment

490 Followers
Argenx SE Boosts Myositis Treatment Development
Premium
Company Announcements
Argenx SE Boosts Myositis Treatment Development
4d ago
6K
ARGX
Argenx and Zai Lab’s CIDP Drug Approved in China
Premium
Company Announcements
Argenx and Zai Lab’s CIDP Drug Approved in China
12d ago
6K
ARGX
Argenx Reports Strong Q3 2024 Financial Results
Premium
Company Announcements
Argenx Reports Strong Q3 2024 Financial Results
24d ago
ARGX
Argenx SE’s Strong Q3 Results and Future Outlook
Premium
Company Announcements
Argenx SE’s Strong Q3 Results and Future Outlook
24d ago
6K
ARGX
Is ARGX a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARGX a Buy, Before Earnings?
27d ago
ARGX
Argenx SE Shows Promising Immunology Program Results
Premium
Company Announcements
Argenx SE Shows Promising Immunology Program Results
1M ago
6K
ARGX
Argenx’s VYVGART Transforming CIDP Treatment
Premium
Company Announcements
Argenx’s VYVGART Transforming CIDP Treatment
2M ago
6K
ARGX
More ARGX News >

ARGX News on the Web

Deep Track Capital, LP Increases Stake in Apellis Pharmaceuticals Inc.
GuruFocus News
Neutral
Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
BioPharma Dive
Neutral
Argenx Se’s Promising Clinical Advancements and Positive ALKIVIA Study Results Underpin Buy Rating
TipRanks News
Bullish
Argenx may have first targeted myositis treatment, says H.C. Wainwright
The Fly
Neutral
Argenx SE Boosts Myositis Treatment Development
TipRanks News
Neutral
RTW INVESTMENTS, LP Acquires Additional Shares in Immunic Inc
GuruFocus News
Neutral
Why Argenx (ARGX) Might be Well Poised for a Surge
Zacks
Bullish
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
Zacks
Neutral

News Score - Last 7 Days

Neutral
ARGX
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARGX’s Media Buzz Sentiment?
5 articles about ARGX were published this week. In an average week, 2.25 articles are published.
    What is ARGX’s weekly average amount of articles?
    In an average week, 2.25 articles about ARGX are published.
      What is ARGX’s News Sentiment?
      100% of articles about ARGX were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        CRDLCardiol Therapeutics
        RCKTRocket Pharmaceuticals
        ACRSAclaris Therapeutics
        ARQTArcutis Biotherapeutics
        NAMSNewAmsterdam Pharma Company
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing